Daniel R. Koeppen

858-350-2393

dkoeppen@wsgr.com

    

Wilson Sonsini

Goodrich & Rosati

12235 El Camino Real

Suite 200

San Diego, CA 92130

T:    858.350.2300

F:    858.350.2399

October 16, 2013

 

CONFIDENTIAL SUBMISSION   
Draft Registration Statement   

U.S. Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

  

Confidential Submission

Pursuant to

Title I, Section 106 under the

Jumpstart Our Business Startups Act

and Section 24(b)(2) of the

Securities Exchange Act of 1934

 

Re:      Inogen, Inc.
     Confidential Submission of Draft Registration Statement on Form S-l

Ladies and Gentlemen:

On behalf of Inogen, Inc., a Delaware corporation (the “Company”), and in connection with the confidential submission of its draft registration statement on Form S-l (the “Registration Statement”) on the date hereof, we hereby confidentially submit the draft Registration Statement pursuant to Title I, Section 106 under the Jumpstart Our Business Startups Act (the “JOBS Act”) and Section 24(b)(2) of the Securities Exchange Act of 1934, as amended, for non-public review by the staff (the “Staff”) of the Securities and Exchange Commission (the “Commission”) prior to the public filing of the Registration Statement.

Pursuant to Title I, Section 101 of the JOBS Act, the Company is an “emerging growth company” that had total annual gross revenues of less than $1.0 billion during its fiscal year ended December 31, 2012. Therefore, the Company is permitted to make this confidential submission of the Registration Statement for review by the Staff, provided that the Registration Statement and all amendments thereto shall be publicly filed with the Commission not later than 21 days before the date on which the Company conducts a “road show,” as such term is defined in Title 17, Section 230.433(h)(4) of the Code of Federal Regulations.

Please direct all notices and communications with respect to this confidential submission to each of the following:

 

   Alison Bauerlein, Chief Financial Officer and VP, Finance
   Inogen, Inc.
   326 Bollay Drive
   Goleta, California 93117
  

Telephone: (805) 562-0504

Facsimile: (805) 879-0739

Email: abauerlein@inogen.net

with a copy to:    Daniel R. Koeppen
   Wilson Sonsini Goodrich & Rosati
   12235 El Camino Real, Suite 200
   San Diego, CA 92130
   Telephone: (858) 350-2300
  

Facsimile: (858) 350-2399

Email: dkoeppen@wsgr.com

Please contact the undersigned at 858-350-2393 or dkoeppen@wsgr.com if you have any questions regarding the foregoing.

 

Very truly yours,

/s/ Daniel R. Koeppen

Daniel R. Koeppen

of Wilson Sonsini Goodrich & Rosati

 

cc: Alison Bauerlein, Chief Financial Officer and VP, Finance, Inogen, Inc.